Data is not available at this time.
TruBridge, Inc. operates in the healthcare technology sector, providing revenue cycle management, electronic health record (EHR) solutions, and business analytics primarily to rural and community healthcare providers. The company’s core revenue model is subscription-based, supplemented by professional services and support fees, ensuring recurring income streams. TruBridge differentiates itself by focusing on underserved healthcare markets, offering tailored solutions that address the unique challenges of smaller providers, such as regulatory compliance and operational efficiency. The company competes in a fragmented industry dominated by larger players but maintains a niche position by emphasizing customer service and localized expertise. Its market positioning is further strengthened by long-term client relationships and a reputation for reliability in critical healthcare IT functions. TruBridge’s ability to integrate financial and clinical workflows provides a competitive edge, though it faces pressure from consolidation trends and evolving technology demands in the broader healthcare IT landscape.
TruBridge reported revenue of $342.6 million for FY 2024, reflecting its steady demand in the healthcare IT space. However, net income was negative at -$20.4 million, with diluted EPS of -$1.38, indicating profitability challenges. Operating cash flow of $32.1 million suggests underlying operational efficiency, though capital expenditures were modest at -$1.6 million, signaling limited reinvestment in growth initiatives.
The company’s negative earnings highlight pressures on margins, likely due to competitive pricing or elevated operating costs. Operating cash flow generation demonstrates some earnings power, but the net loss raises questions about capital allocation. With minimal capex, TruBridge appears to prioritize liquidity over expansion, potentially limiting future scalability in a rapidly evolving industry.
TruBridge’s balance sheet shows $12.3 million in cash against $174.8 million in total debt, indicating a leveraged position. The debt burden may constrain financial flexibility, though the positive operating cash flow provides some cushion. Shareholders’ equity is likely under pressure given the net loss, warranting close monitoring of covenant compliance and refinancing risks.
Revenue stability suggests resilience, but the lack of profitability and no dividend payments reflect a focus on preserving capital. Growth trends appear muted, with limited capex signaling organic expansion challenges. The company may need strategic acquisitions or product innovation to reignite top-line momentum in a competitive market.
The negative EPS and high debt load likely weigh on valuation multiples. Market expectations seem tempered, with investors pricing in turnaround risks. A premium would require demonstrated progress toward profitability or debt reduction, neither of which is evident in the current fiscal year.
TruBridge’s niche focus on rural healthcare providers offers defensive qualities, but its financial performance raises execution concerns. The outlook hinges on improving operational efficiency and leveraging its specialized expertise to offset industry headwinds. Success will depend on balancing cost discipline with targeted investments in high-potential segments like analytics or cloud-based solutions.
Company filings (10-K), CIK 0001169445
show cash flow forecast
Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
Revenue growth rate, % | NaN | |||||||||||||||||||||||||
Revenue, $ | NaN | |||||||||||||||||||||||||
Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
Total operating expenses, $m | NaN | |||||||||||||||||||||||||
Operating income, $m | NaN | |||||||||||||||||||||||||
EBITDA, $m | NaN | |||||||||||||||||||||||||
Interest expense (income), $m | NaN | |||||||||||||||||||||||||
Earnings before tax, $m | NaN | |||||||||||||||||||||||||
Tax expense, $m | NaN | |||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
Total assets, $m | NaN | |||||||||||||||||||||||||
Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
Average production assets, $m | NaN | |||||||||||||||||||||||||
Working capital, $m | NaN | |||||||||||||||||||||||||
Total debt, $m | NaN | |||||||||||||||||||||||||
Total liabilities, $m | NaN | |||||||||||||||||||||||||
Total equity, $m | NaN | |||||||||||||||||||||||||
Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
Funds from operations, $m | NaN | |||||||||||||||||||||||||
Change in working capital, $m | NaN | |||||||||||||||||||||||||
Cash from operations, $m | NaN | |||||||||||||||||||||||||
Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
New CAPEX, $m | NaN | |||||||||||||||||||||||||
Total CAPEX, $m | NaN | |||||||||||||||||||||||||
Free cash flow, $m | NaN | |||||||||||||||||||||||||
Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
Discount rate, % | NaN | |||||||||||||||||||||||||
PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
Current shareholders' claim on cash, % | NaN |